Doctors are reassessing decades of standard treatment for patients who have had heart attacks after new research shows beta-blockers may be anywhere from useless to harmful in certain cases. The ...

A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Beta blockers—drugs commonly prescribed after a heart attack—may not ...

Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily, new study suggests. Half of all patients discharged from hospital after a heart attack ...

ATLANTA — Beta blockers are a mainstay in cardiovascular treatment, frequently given to patients after heart attacks. But a new large trial turns that convention on its head, suggesting that the drugs ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

A drug commonly prescribed after a heart attack doesn’t seem to offer significant benefits for people who recover without lasting damage — and could pose added risks to women. In a new research trial, ...

For roughly four decades, the playbook after a heart attack has included a near-automatic prescription: beta-blockers, taken ...